Novogene(SH:688315)2021-04-26 16:00Financial Performance - Operating revenue for the period was CNY 365,313,175.51, representing a year-on-year increase of 64.08%[11] - Net profit attributable to shareholders was CNY 32,905,014.46, a significant recovery from a loss of CNY 62,394,023.64 in the same period last year[11] - Basic earnings per share were CNY 0.09, a recovery from a loss of CNY 0.17 per share in the previous year[11] - Operating profit for Q1 2021 was ¥37,916,476.22, recovering from a loss of ¥64,592,401.88 in Q1 2020[47] - Net profit for Q1 2021 amounted to ¥33,619,210.00, compared to a net loss of ¥63,207,392.64 in the same period last year[47] - The total cost of operations in Q1 2021 was ¥349,964,016.66, up from ¥286,646,888.04 in Q1 2020, reflecting a 22.1% increase[45] - The company reported a tax expense of ¥4,294,920.01 for Q1 2021, compared to a tax benefit of ¥1,795,267.22 in Q1 2020[47] - Other comprehensive income after tax for Q1 2021 was ¥2,002,454.65, up from ¥490,055.87 in Q1 2020[47] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,007,328,739.87, a decrease of 0.86% compared to the end of the previous year[11] - The total current assets decreased to ¥1,119,237,608.85 from ¥1,201,864,828.81, reflecting a reduction in other current assets[29] - Total assets decreased from CNY 2,024,732,082.96 to CNY 2,007,328,739.87, a decline of approximately 0.8%[32] - Current liabilities decreased from CNY 897,478,042.40 to CNY 807,671,119.88, a reduction of about 10%[32] - Total liabilities decreased from CNY 903,855,566.28 to CNY 850,798,497.96, a reduction of approximately 5.9%[34] - The company’s total non-current assets increased from CNY 712,695,154.27 to CNY 712,425,212.36, a slight decrease of about 0.4%[38] - The total liabilities decreased to ¥539,293,226.67 from ¥686,203,389.96 year-over-year, a reduction of approximately 21.5%[40] - The total assets decreased to ¥1,584,757,463.30 from ¥1,729,595,807.47, reflecting a decline of approximately 8.4%[40] Cash Flow - The net cash flow from operating activities improved to CNY -139,732,903.79, compared to CNY -315,651,953.34 in the same period last year[11] - Cash flow from operating activities for Q1 2021 was negative at approximately -¥139.73 million, an improvement from -¥315.65 million in Q1 2020[53] - Cash inflow from operating activities totaled 139,533,644.53 RMB, compared to 102,799,757.35 RMB in the same period last year, representing a 35.7% increase[62] - Cash outflow from operating activities decreased to 302,051,772.62 RMB from 411,103,818.05 RMB, indicating a reduction of approximately 26.5%[62] - The company reported cash inflow from investment activities of approximately ¥240.41 million in Q1 2021, compared to ¥236.35 million in Q1 2020[53] Shareholder Information - The total number of shareholders at the end of the reporting period was not specified, but significant shareholders include Li Ruiqiang with 15.2% ownership[12] - The total equity attributable to shareholders was CNY 1,116,250,391.49, with minority interests at CNY 4,626,125.19[69] - Shareholders' equity totaled CNY 1,043,392,417.51, reflecting an increase in undistributed profits to CNY 215,083,430.92[73] Research and Development - Research and development expenses accounted for 7.65% of operating revenue, down 3.56 percentage points from the previous year[11] - Research and development expenses for Q1 2021 were ¥27,956,011.94, compared to ¥24,947,377.57 in Q1 2020, indicating a 12.1% increase[45] - The company has not disclosed any major new product developments or market expansion strategies in this report[18] Government Support - The company received government subsidies amounting to CNY 15,122,383.55 during the reporting period[14] Other Financial Metrics - The weighted average return on equity increased by 8.83 percentage points to 2.90%[11] - The company reported a significant increase in other income, which reached ¥15,122,383.55, up 1,131.08% from ¥1,228,387.89, primarily due to increased VAT deductions[23] - The investment income increased to ¥578,107.97, a 66.19% rise from ¥347,866.04, due to higher dividends from financial assets[23] - The company’s short-term borrowings decreased by 53.65% to ¥33,030,050.00 from ¥71,262,494.16, indicating repayment of bank loans[20]